Human medicines European public assessment report (EPAR): Airexar Spiromax, salmeterol xinafoate / fluticasone propionate, Pulmonary Disease, Chronic Obstructive,Asthma, Date of authorisation: 18/08/2016, Revision: 2, Status: Withdrawn - Withdrawal Notice | RetractBase